Skip to main content

levodopa/carbidopa/entacapone (Lecigon®)

 

Appraisal in progress

Indication

Status: In progress

Treatment of advanced Parkinson's disease with severe motor fluctuations and hyperkinesia or dyskinesia when available oral combinations of Parkinson medicinal products have not given satisfactory results

Medicine details

Medicine name levodopa/carbidopa/entacapone (Lecigon®)
Formulation 20 mg/ml 5 mg/ml 20 mg/ml intestinal gel
Reference number 4871
Indication

As above

Company Britannia Pharmaceuticals
BNF chapter Central nervous system
Submission type Full
Status In progress
NMG meeting date TBC
AWMSG meeting date TBC
Date of issue TBA
Follow AWTTC: